Epcoritamab

Records for this ingredient, by country (identity only).

ATC L01FX27 · 12 markets · 26 records

Epcoritamab 12 markets · 26 records Forms
Filters
MarketAU 5HK 3US 2GB 2CA 2SG 2ES 2TW 2JP 2FR 2MX 1EU 1

AU 5 records · 4 shown of 4 Source TGA、PBS Schedule API v3 (Department of +1 · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

  • 4 mg/0.8 mLinjectionEPKINLY also in US·GB·SG
    +4Other 4 marketsESTWJPFR
  • 48 mg/0.8 mLinjectionEPKINLY also in US·GB·SG
    +3Other 3 marketsTWJPFR
  • 60 mg/mL per mL / per unit basis not statedinjectionEPKINLY epcoritamab 48mg/0.8mL solution for injection vial unknown
  • 5 mg/mL per mL / per unit basis not statedinjectionEPKINLY epcoritamab 4mg/0.8mL concentrate solution for injection vial unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名EPKINLY ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

HK 3 records · 0 shown of 0 Source 衞生署藥物辦公室（香港）註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

3 records · 0 manufacturers 3 registros · 0 fabricantes 3 个记录 · 0 个厂家 3 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名EPKINLY CONCENTRATE FOR SOLUTION FOR INJECTION 4MG/0.8ML ×1EPKINLY Solution for Injection 48 mg/0.8 mL ×8

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

US 2 records · 2 shown of 2 Source openFDA NDC Directory · Data as of 2026-10-23

GB 2 records · 2 shown of 2 Source NHSBSA dm+d · Data as of 2026-10-19

  • 4 mg/0.8 mLinjectionTepkinly 4mg/0.8ml concentrate for solution for injection vials also in AU·US·SG
    +4Other 4 marketsESTWJPFR
  • 48 mg/0.8 mLinjectionTepkinly 48mg/0.8ml solution for injection vials also in AU·US·SG
    +3Other 3 marketsTWJPFR

CA 2 records · 2 shown of 2 Source Health Canada Drug Product Databas · Data as of 2026-10-23

  • 60 mg per mL / per unit basis not statedliquidEPKINLY
  • 5 mg per mL / per unit basis not statedliquidEPKINLY

SG 2 records · 2 shown of 2 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

ES 2 records · 2 shown of 2 Source CIMA (AEMPS) · Data as of live

TW 2 records · 2 shown of 2 Source 衛生福利部食品藥物管理署（TFDA）全部藥品許可證資料集 · Data as of 2026-10-22

JP 2 records · 2 shown of 2 Source 厚生労働省 薬価基準収載品目リスト · Data as of 2026-11-01

FR 2 records · 2 shown of 2 Source Base de données publique des médic · Data as of 2026-11-03

MX 1 records · 0 shown of 0 Source COFEPRIS · Data as of annual · some records have no stated strength

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名EPKINLY ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名TEPKINLY ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.